ENTITY
Hisamitsu Pharmaceutical Co

Hisamitsu Pharmaceutical Co (4530 JP)

37
Analysis
Health CareJapan
HISAMITSU PHARMACEUTICAL CO., INC. produces and sells pharmaceutical products. The Company's main product is anti-inflammatory analgesic plasters and poultices sold under the brand name Salonpas. Hisamitsu Pharmaceutical exports its products to North America and Southeast Asia. The Company also researches and develops antibacterial products through its related company, RRF.
more
Refresh
27 Jan 2022 01:00

Sawai Pharmaceutical: Big Capacity Expansion Planned Amid Supply Shortages to Drive Market Share

By chalking out a huge capacity expansion plan and new product launches, Sawai is expected to enhance market share in Japan generic drug market,...

Logo
211 Views
Share
14 Dec 2021 23:03

Hisamitsu Pharmaceutical (4530 JP): Focus Shifts to ADHD Treatment Patch and Other Upcoming Launches

While our bear case still holds good for the company, near-term focus is now shifting to new launches and upcoming approvals. Hisamitsu is expected...

Logo
262 Views
Share
10 Oct 2021 22:30

Hisamitsu Pharmaceutical (4530 JP): Avoid as More Pain Ahead

Shares of Hisamitsu is trading near 52-week low. However, investors should avoid the stock ahead of its Q2 results announcement due to near-term...

Logo
289 Views
Share
bullishSG Holdings
07 Aug 2021 11:41

JPX Nikkei 400 Index Rebalance: Big Turnover, Big Impact & A Market Consultation

There are 41 adds and 40 deletes for the JPX NK 400 Index. One-way turnover is high at 8.16% and will result in a trade of JPY 468bn. There will be...

Logo
449 Views
Share
09 Apr 2021 06:47

🇯🇵 JAPAN • Results & Revisions 04/​​​​08 - 7&I Fast Re and Hisamitsu Dreams

RESULTS - 48% of Thursday's 29 results announcements scored positively; however, of the largest caps, only Fast Retailing (9983 JP) and Shift (3697...

Logo
359 Views
Share
x